Supplemental Figure 1. Flowchart of included patients Supplemental Table 1. Characteristics of the study population Supplemental Table 2. Subgroup analysis on the risk of vitiligo by HSCT graft type,
The table shows the identity of each of the two alleles of HLA-A, HLA-B and HLA-C for two melanoma patients (Mel008 and Mel10) and seven healthy NK donors (depicted as “HD” followed by a serial number
